Association of oxidative stress and serum adiponectin in patients with metabolic syndrome

Journal of Sichuan University (Medical Science)

Volumn 40, Issue 4, 2009, Pages 623-627

  He, Qiu Rong ^a   Yu, Ting ^a   Li, Ping ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Adiponectin; Malondialdehyde; Metabolic syndrome; Oxidative stress; Reduced glutathione

Indexed keywords

EID: 68149170718     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Dominique BR. Glucose and reactive oxygen species. Curr Opin Clin Nutr Metab Care,2002;5(5) :561-568.
2. Shima T. Shinda T, Satito T, et al. Effect of high glucose concentration on mitochondrial metabolism in neuronal cells. Yamanashi Medical Journal,2005;19(4) : 107-116.
3. Dominique D, Bruno G, Christiane C, et al. Metformin prevents high-glucose induced endothelial cell death through a mitochondrial permeability transition-dependent process. Diabetes,2005,54(7) :2179-2187.
4. Xie L, Zhu X, Hu Y, et al. Mitochondrial DNA oxidative damage triggering mitochondrial dysfunction and apoptosis in high glucose-induced HRECs. Invest Ophthalmol Vis Sci, 2008,49(9) :4203-4209.
5. Takashi K, Toshimasa Y. Adiponectin and adiponectin receptors. End Rev,2005,26(3),439-451.
6. Ouedraogo R, Wu X, Xu SQ, et al. Adiponectin suppression of high-glucose-induced reactive oxygen species in vascular endothelial cells. Diabetes,2006,55(6), 1840-1846.2004,12(3),156-161.
7. Chinese Sourse
8. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications, Report of a WHO Consultation. Geneva,WHO, 1999.
9. Ebinuma H, Miyazaki O, Yago H, et al. A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clinica Chimica Acta,2006,372(1-2),47-53.
10. Spector A. Review, oxidative stress and disease. J Ocul Pharmacol Ther,2000,16(2), 193-201.
11. Orit PK, Tali S, Ariela B, et al. Oxidative stress as determined by glutathione(GSH) concentrations in venous cord blood in elective cesarean delivery versus uncomplicated vaginal delivery. Arch Gynecol Obstet,2007;276(l) :43-46.
12. Isabella DD, Ranieri R, Roberto C, et al. Biomarkers of oxidative damage in human disease. Clin Chem, 2006 ; 52(4) : 601-623.
13. Slater DA, Bolton CH, Bailey AJ, et al. The importance of lipid-derived malondialdehyde in diabetes mellitus. Diabetologia,2000i43(5) :550-557.
14. Shaibi GQ, Gruz ML, Weigensberg MJ, et al. Adiponectin independently predicts metabolic syndrome in overweight Latino youth. J Clin Endocrinol Metab, 2007; 92(5) : 1809- 1813.
15. Cristina LC, Luo N, Wallace P, et al. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes, 2006!55(1),249-259.
16. Hara K, Horikoshi M, Yamauchi T, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care,2006;29(6), 1357-1362.
17. Nakanishi S, Yamane K, Kamei N, et al. A protective effect of adiponectin against oxidative stress in Japanese Americans.- the association between adiponectin or leptin and urinary isoprostane. Metabolism,2006; 54(2) :194-199.
18. Karmigaki M, Sakaue S, Tsujino I, et al. Oxidative stress provokes atherogenic changes in adipokine gene expression in 3T3-L1 adipocytes. Biochem Bophys Res Commun, 2006; 339(2):624-632.
19. Plant S, Shand B, Elder P, et al. Adiponectin attenuates endothelial dysfunction induced by oxidised low-density lipoproteins. Diab Vase Dis Res,2008;5(2) :l02-108.
20. Zietz B, Herfarth H, Paul G, et al. Adiponectin represents an independent cardiovascular risk factor predicting serum HDL- cholesterol levels in type 2 diabetes. FEBS Letters, 2003;545(2-3): 103-104.